Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP645019.RA5arAc5-dMbZ40E9JGw5asz8MaAhDRDFAdpws34QpwHc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP645019.RA5arAc5-dMbZ40E9JGw5asz8MaAhDRDFAdpws34QpwHc130_assertion type Assertion NP645019.RA5arAc5-dMbZ40E9JGw5asz8MaAhDRDFAdpws34QpwHc130_head.
- NP645019.RA5arAc5-dMbZ40E9JGw5asz8MaAhDRDFAdpws34QpwHc130_assertion wasGeneratedBy ECO_0000203 NP645019.RA5arAc5-dMbZ40E9JGw5asz8MaAhDRDFAdpws34QpwHc130_provenance.
- NP645019.RA5arAc5-dMbZ40E9JGw5asz8MaAhDRDFAdpws34QpwHc130_assertion wasDerivedFrom befree-20150227 NP645019.RA5arAc5-dMbZ40E9JGw5asz8MaAhDRDFAdpws34QpwHc130_provenance.
- NP645019.RA5arAc5-dMbZ40E9JGw5asz8MaAhDRDFAdpws34QpwHc130_assertion SIO_000772 21703428 NP645019.RA5arAc5-dMbZ40E9JGw5asz8MaAhDRDFAdpws34QpwHc130_provenance.
- NP645019.RA5arAc5-dMbZ40E9JGw5asz8MaAhDRDFAdpws34QpwHc130_assertion evidence source_evidence_literature NP645019.RA5arAc5-dMbZ40E9JGw5asz8MaAhDRDFAdpws34QpwHc130_provenance.
- NP645019.RA5arAc5-dMbZ40E9JGw5asz8MaAhDRDFAdpws34QpwHc130_assertion description "[We identify the PAR1-ERK1/2 pathway as a feasible target for therapy in lung cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP645019.RA5arAc5-dMbZ40E9JGw5asz8MaAhDRDFAdpws34QpwHc130_provenance.